Michael Goettler, Viatris CEO

Vi­a­tris weighs sale of Eu­ro­pean con­sumer health busi­ness — re­port

Fol­low­ing in the foot­steps of GSK and J&J, Vi­a­tris is re­port­ed­ly weigh­ing plans to ditch its con­sumer health as­sets.

Vi­a­tris is con­sid­er­ing a deal for its Eu­ro­pean con­sumer health pro­grams that could reap more than $2.9 bil­lion, un­named sources told Bloomberg. While Vi­a­tris hasn’t re­spond­ed to a re­quest for com­ment, CEO Michael Goet­tler has pre­vi­ous­ly made clear that he’s on a mis­sion to trim back the com­pa­ny’s “non-core as­sets.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.